Modulation of EZH2 expression by MEK-ERK or PI3K-AKT signaling in lung cancer is dictated by different KRAS oncogene mutations

Erick Riquelme, Carmen Behrens, Heather Y. Lin, George Simon, Vassiliki Papadimitrakopoulou, Julie Izzo, Cesar Moran, Neda Kalhor, J. Jack Lee, John D. Minna, Ignacio I. Wistuba

Research output: Contribution to journalArticlepeer-review

72 Scopus citations

Fingerprint

Dive into the research topics of 'Modulation of EZH2 expression by MEK-ERK or PI3K-AKT signaling in lung cancer is dictated by different KRAS oncogene mutations'. Together they form a unique fingerprint.

Medicine & Life Sciences